21 results
S-1/A
EX-10.3
AXLA
Axcella Health Inc.
30 Apr 19
IPO registration (amended)
6:06am
, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification, remain
S-1/A
EX-10.16
AXLA
Axcella Health Inc.
30 Apr 19
IPO registration (amended)
6:06am
or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing
8-K
EX-10.1
9dkp2z7yphvkzef7mm6
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
9p6op5vc
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
EX-10.1
czqp jgadcrfv
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
cqi9c49
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
5exiz3j gsuawb9
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B4
4wl93qy ra
9 May 19
Prospectus supplement with pricing info
4:29pm
DRS/A
k9lrij8
15 Mar 19
Draft registration statement (amended)
12:00am
S-1/A
i785 fkji72ms
30 Apr 19
IPO registration (amended)
6:06am
DRS
gqblfyl50p0msz9
28 Jan 19
Draft registration statement
12:00am
S-1
61fhz1dj u04
12 Apr 19
IPO registration
7:02am